Cargando…
Improving the Breadth of the Host’s Immune Response to Lassa Virus
In 2017, the global Coalition for Epidemic Preparedness (CEPI) declared Lassa virus disease to be one of the world’s foremost biothreats. In January 2018, World Health Organization experts met to address the Lassa biothreat. It was commonly recognized that the diversity of Lassa virus (LASV) isolate...
Autores principales: | Zapata, Juan Carlos, Medina-Moreno, Sandra, Guzmán-Cardozo, Camila, Salvato, Maria S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313495/ https://www.ncbi.nlm.nih.gov/pubmed/30373278 http://dx.doi.org/10.3390/pathogens7040084 |
Ejemplares similares
-
A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge
por: Salvato, Maria S., et al.
Publicado: (2019) -
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
por: Zapata, Juan C, et al.
Publicado: (2013) -
Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate
por: Zapata, Juan Carlos, et al.
Publicado: (2013) -
New Hosts of The Lassa Virus
por: Olayemi, Ayodeji, et al.
Publicado: (2016) -
Immune Responses and Lassa Virus Infection
por: Russier, Marion, et al.
Publicado: (2012)